Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits

 Breaking News
  • No posts were found

Creative Diagnostics Announces New Polyethylene Glycol Antibodies Detection Kits

October 27
10:03 2022
Creative Diagnostics announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma.

New York, USA – October 27, 2022 – Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of a panel of anti-PEG IgG or IgM ELISA kits with different species reactivity to detect anti-PEG IgG or IgM in serum and plasma. More importantly, these kits can be used in a broad range of scientific research and vaccine evaluation.

Polyethylene glycol (PEG) is a classic non-scaling water-soluble synthetic polymer widely used in the pharmaceutical field for proteins and drug carriers. The covalent conjugation process of PEG to proteins and drug carriers, known as pegylation, is critical for maintaining the colloidal stability of drugs in biological fluids and reducing their uptake by filtering organs, improving the overall efficacy and safety after inoculation.

Therefore, an in-depth understanding of the incidence and clinical significance of anti-PEG immunity is essential for the continued clinical application of PEGylated therapeutics. Creative Diagnostics now offers a set of anti-PEG IgG or IgM ELISA kits with different species reactivity for the detection of anti-PEG IgG or IgM in serum and plasma. These kits can be used for scientific research and vaccine evaluation.

For example, Creative Diagnostics supplies High Sensitivity Polyethylene Glycol (PEG) ELISA Kit (Catalog # DEIA6158) for research applications, which can be used to detect proteins containing one or more PEG chains as well